These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
177 related articles for article (PubMed ID: 7448771)
1. Antitumor effect of the antiestrogen, tamoxifen, ona pregnancy-dependent mouse mammary tumor (TPDMT-4). Matsuzawa A; Mizuno Y; Yamamoto T Cancer Res; 1981 Jan; 41(1):316-24. PubMed ID: 7448771 [TBL] [Abstract][Full Text] [Related]
2. Antitumor effect of two oral steroids, mepitiostane and fluoxymesterone, on a pregnancy-dependent mouse mammary tumor (TPDMT-4). Matsuzawa A; Yamamoto T Cancer Res; 1977 Dec; 37(12):4408-15. PubMed ID: 922732 [TBL] [Abstract][Full Text] [Related]
3. Inhibited growth in vivo of a mouse pregnancy-dependent mammary tumor (TPDMT-4) by an antiestrogen, 2alpha, 3alpha-epithio-5alpha-androstan-17beta-ol (10275-S). Matsuzawa A; Yamamoto T Cancer Res; 1976 May; 36(5):1598-606. PubMed ID: 178425 [TBL] [Abstract][Full Text] [Related]
4. Antitumor actions of keoxifene and tamoxifen in the N-nitrosomethylurea-induced rat mammary carcinoma model. Gottardis MM; Jordan VC Cancer Res; 1987 Aug; 47(15):4020-4. PubMed ID: 3607747 [TBL] [Abstract][Full Text] [Related]
5. Differential response of an ovarian-responsive mouse mammary tumor to androgenic and estrogenic agents. Matsuzawa A; Ikeda Y Cancer Res; 1983 Aug; 43(8):3680-6. PubMed ID: 6861137 [TBL] [Abstract][Full Text] [Related]
6. Enhanced and reversed growth in vitro of a pregnancy-dependent mouse mammary tumor (TPDMT-4) by a gonadotropin-releasing hormone agonist analog. Matsuzawa A; Yamamoto T Eur J Cancer Clin Oncol; 1982 May; 18(5):495-505. PubMed ID: 6811279 [TBL] [Abstract][Full Text] [Related]
7. Response of a pregnancy-dependent mouse mammary tumor to hormones. Matsuzawa A; Yamamoto T J Natl Cancer Inst; 1975 Aug; 55(2):447-53. PubMed ID: 1159826 [TBL] [Abstract][Full Text] [Related]
8. Comparison of the actions of the antiprogestin mifepristone (RU486), the progestin megestrol acetate, the LHRH analog buserelin, and ovariectomy in treatment of rat mammary tumors. Bakker GH; Setyono-Han B; Henkelman MS; de Jong FH; Lamberts SW; van der Schoot P; Klijn JG Cancer Treat Rep; 1987 Nov; 71(11):1021-7. PubMed ID: 3119199 [TBL] [Abstract][Full Text] [Related]
9. Accelerated progression to autonomy of a pregnancy-dependent mouse mammary tumor (TPDMT-4) by hormones. Matsuzawa A; Kaneko T; Ikeda Y Cancer Res; 1983 May; 43(5):2283-9. PubMed ID: 6831452 [TBL] [Abstract][Full Text] [Related]
10. Embryonal mass and hormone-associated effects of pregnancy inducing a differential growth of four murine tumors. Bustuoabad OD; di Gianni PD; Franco M; Kordon EC; Vanzulli SI; Meiss RP; Grion LC; Díaz GS; Nosetto SH; Hockl P; Lombardi MG; Pasqualini CD; Ruggiero RA Oncol Res; 2002; 13(3):147-60. PubMed ID: 12549624 [TBL] [Abstract][Full Text] [Related]
11. Antitumor action of physiological estradiol on tamoxifen-stimulated breast tumors grown in athymic mice. Yao K; Lee ES; Bentrem DJ; England G; Schafer JI; O'Regan RM; Jordan VC Clin Cancer Res; 2000 May; 6(5):2028-36. PubMed ID: 10815929 [TBL] [Abstract][Full Text] [Related]
12. Cytoplasmic estrogen receptor in a pregnancy-dependent mouse mammary tumor (TPDMT-4) and related autonomous lines. Matsuzawa A; Mizuno Y; Yamamoto T; Hori T; Suzuki T Cancer Res; 1980 Sep; 40(9):3361-8. PubMed ID: 7427949 [TBL] [Abstract][Full Text] [Related]
13. Dichotomous effects of tamoxifen on a transplantable rat mammary tumor. Ip MM; Milholland RJ; Rosen F; Kim U Cancer Res; 1981 Mar; 41(3):984-8. PubMed ID: 7459886 [TBL] [Abstract][Full Text] [Related]
14. Effects of a new clinically relevant antiestrogen (GW5638) related to tamoxifen on breast and endometrial cancer growth in vivo. Dardes RC; O'Regan RM; Gajdos C; Robinson SP; Bentrem D; De Los Reyes A; Jordan VC Clin Cancer Res; 2002 Jun; 8(6):1995-2001. PubMed ID: 12060645 [TBL] [Abstract][Full Text] [Related]
15. Tumor-inhibiting potential of ZK 112.993, a new progesterone antagonist, in hormone-sensitive, experimental rodent and human mammary tumors. Schneider MR; Michna H; Nishino Y; Neef G; el Etreby MF Anticancer Res; 1990; 10(3):683-7. PubMed ID: 2369083 [TBL] [Abstract][Full Text] [Related]
16. Regression of a pregnancy-dependent mouse mammary tumor (TP-DMT-4) by the antiestrogen, tamoxifen. Matsuzawa A; Yamamoto T Gan; 1979 Jun; 70(3):387-8. PubMed ID: 467901 [No Abstract] [Full Text] [Related]
17. 3H-thymidine incorporation into mammary carcinoma cells obtained by needle aspiration before and during endocrine therapy. Nordenskjöld B; Löwhagen T; Westerberg H; Zajicek J Acta Cytol; 1976; 20(2):137-43. PubMed ID: 1065173 [TBL] [Abstract][Full Text] [Related]
18. Hormonal and dietary modulation of mammary carcinogenesis in mouse mammary tumor virus-c-erbB-2 transgenic mice. Yang X; Edgerton SM; Kosanke SD; Mason TL; Alvarez KM; Liu N; Chatterton RT; Liu B; Wang Q; Kim A; Murthy S; Thor AD Cancer Res; 2003 May; 63(10):2425-33. PubMed ID: 12750262 [TBL] [Abstract][Full Text] [Related]
19. Flaxseed alone or in combination with tamoxifen inhibits MCF-7 breast tumor growth in ovariectomized athymic mice with high circulating levels of estrogen. Chen J; Power KA; Mann J; Cheng A; Thompson LU Exp Biol Med (Maywood); 2007 Sep; 232(8):1071-80. PubMed ID: 17720953 [TBL] [Abstract][Full Text] [Related]
20. Somatostatin analogue octreotide enhances the antineoplastic effects of tamoxifen and ovariectomy on 7,12-dimethylbenz(alpha)anthracene-induced rat mammary carcinomas. Weckbecker G; Tolcsvai L; Stolz B; Pollak M; Bruns C Cancer Res; 1994 Dec; 54(24):6334-7. PubMed ID: 7987824 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]